Multiple Myeloma Archives - Page 2 of 5 - Together4Cancer Compass

Patients

HCPs

Home

Categories

Real-world outcomes with elranatamab in multiple myeloma: a multicenter analysis from the U.S. Multiple Myeloma Immunotherapy Consortium.

Post category:Hematologic Cancers
Reading time:2 mins read

This multicenter U.S. retrospective study evaluated 130 relapsed/refractory multiple myeloma patients treated with comme...

Continue Reading

Linvoseltamab versus real-world International Myeloma Working Group standard-of-care in triple-class exposed relapsed/refractory multiple myeloma.

Post category:Hematologic Cancers
Reading time:2 mins read

This publication reports an external control comparison of linvoseltamab, a BCMA×CD3 bispecific antibody, in heavily pr...

Continue Reading

Patients’, clinicians’ and research’s priorities on important outcomes in multiple myeloma: A mixed-methods study.

Post category:Hematologic Cancers
Reading time:2 mins read

This study examined how outcome priorities differ among patients with multiple myeloma, clinicians, and randomized contr...

Continue Reading

Immunoglobulin supplementation and longer dosing intervals reduce risk of infections in patients with RRMM treated with teclistamab.

Post category:Hematologic Cancers
Reading time:1 min read

Study type and population - Single-center retrospective cohort of 80 patients with relapsed/refractory multiple myelom...

Continue Reading

Validation of the 2025 IMS/IMWG risk classification in patients with newly diagnosed multiple myeloma treated with quadruplets and autologous stem cell transplant.

Post category:Hematologic Cancers
Reading time:2 mins read

Study focus The authors evaluated whether recently proposed 2025 International Myeloma Society/International Myeloma W...

Continue Reading

In Vivo CAR T Cells Deliver Deep Responses in Myeloma.

Post category:Hematologic Cancers
Reading time:1 min read

This report describes early clinical results of an in vivo CAR T-cell approach for relapsed multiple myeloma, in which p...

Continue Reading